Huakang Biomedical Holdings Company Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was CNY 7.284 million compared to CNY 5.152 million a year ago. Net loss was CNY 900,000 compared to CNY 3.354 million a year ago. Basic loss per share from continuing operations was CNY 0.0021 compared to CNY 0.0084 a year ago. For the half year, sales was CNY 12.172 million compared to CNY 7.208 million a year ago. Net loss was CNY 2.049 million compared to CNY 6.107 million a year ago. Basic loss per share from continuing operations was CNY 0.0051 compared to CNY 0.0153 a year ago.